Decreased Expression of Endometrial Decay Accelerating Factor (DAF), a Complement Regulatory Protein, in Patients With Luteal Phase Defect

Anil Kaul, MANUBAI NAGAMANI, BOGDAN NOWICKI

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

PROBLEM: We investigated the level of decay accelerating factor (DAF) in the endometrium of luteal phase defect (LPD) patients, before and after treatment with progesterone. METHODS: Endometrial samples from fourteen normal‐cycling controls and six samples from infertility patients with LPD before and four samples after progesterone treatment were stained by anti‐DAF IgG using immunohistochemistry. RESULTS: Mean DAF OD in LPD patients was 15% compared to 60% in the control group. The mean DAF OD was 88% after treatment with progesterone. CONCLUSION: Results support interpretation that progesterone upregulates DAF while decreased progesterone may be associated with reduced expression of the DAF in LPD patients. 1995 Munksgaard

Original languageEnglish
Pages (from-to)236-240
Number of pages5
JournalAmerican Journal of Reproductive Immunology
Volume34
Issue number4
DOIs
StatePublished - 1 Jan 1995

Fingerprint

CD55 Antigens
Luteal Phase
Progesterone
Complement System Proteins
Endometrium
Infertility
Up-Regulation
Therapeutics
Immunoglobulin G
Immunohistochemistry
Control Groups

Keywords

  • Progesterone
  • abortions
  • endometrium
  • implantations
  • infertility

Cite this

@article{53a5ce9bc2074123b7eb4ca47cd76976,
title = "Decreased Expression of Endometrial Decay Accelerating Factor (DAF), a Complement Regulatory Protein, in Patients With Luteal Phase Defect",
abstract = "PROBLEM: We investigated the level of decay accelerating factor (DAF) in the endometrium of luteal phase defect (LPD) patients, before and after treatment with progesterone. METHODS: Endometrial samples from fourteen normal‐cycling controls and six samples from infertility patients with LPD before and four samples after progesterone treatment were stained by anti‐DAF IgG using immunohistochemistry. RESULTS: Mean DAF OD in LPD patients was 15{\%} compared to 60{\%} in the control group. The mean DAF OD was 88{\%} after treatment with progesterone. CONCLUSION: Results support interpretation that progesterone upregulates DAF while decreased progesterone may be associated with reduced expression of the DAF in LPD patients. 1995 Munksgaard",
keywords = "Progesterone, abortions, endometrium, implantations, infertility",
author = "Anil Kaul and MANUBAI NAGAMANI and BOGDAN NOWICKI",
year = "1995",
month = "1",
day = "1",
doi = "10.1111/j.1600-0897.1995.tb00947.x",
language = "English",
volume = "34",
pages = "236--240",
journal = "American Journal of Reproductive Immunology",
issn = "8755-8920",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

Decreased Expression of Endometrial Decay Accelerating Factor (DAF), a Complement Regulatory Protein, in Patients With Luteal Phase Defect. / Kaul, Anil; NAGAMANI, MANUBAI; NOWICKI, BOGDAN.

In: American Journal of Reproductive Immunology, Vol. 34, No. 4, 01.01.1995, p. 236-240.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Decreased Expression of Endometrial Decay Accelerating Factor (DAF), a Complement Regulatory Protein, in Patients With Luteal Phase Defect

AU - Kaul, Anil

AU - NAGAMANI, MANUBAI

AU - NOWICKI, BOGDAN

PY - 1995/1/1

Y1 - 1995/1/1

N2 - PROBLEM: We investigated the level of decay accelerating factor (DAF) in the endometrium of luteal phase defect (LPD) patients, before and after treatment with progesterone. METHODS: Endometrial samples from fourteen normal‐cycling controls and six samples from infertility patients with LPD before and four samples after progesterone treatment were stained by anti‐DAF IgG using immunohistochemistry. RESULTS: Mean DAF OD in LPD patients was 15% compared to 60% in the control group. The mean DAF OD was 88% after treatment with progesterone. CONCLUSION: Results support interpretation that progesterone upregulates DAF while decreased progesterone may be associated with reduced expression of the DAF in LPD patients. 1995 Munksgaard

AB - PROBLEM: We investigated the level of decay accelerating factor (DAF) in the endometrium of luteal phase defect (LPD) patients, before and after treatment with progesterone. METHODS: Endometrial samples from fourteen normal‐cycling controls and six samples from infertility patients with LPD before and four samples after progesterone treatment were stained by anti‐DAF IgG using immunohistochemistry. RESULTS: Mean DAF OD in LPD patients was 15% compared to 60% in the control group. The mean DAF OD was 88% after treatment with progesterone. CONCLUSION: Results support interpretation that progesterone upregulates DAF while decreased progesterone may be associated with reduced expression of the DAF in LPD patients. 1995 Munksgaard

KW - Progesterone

KW - abortions

KW - endometrium

KW - implantations

KW - infertility

UR - http://www.scopus.com/inward/record.url?scp=0028789319&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0897.1995.tb00947.x

DO - 10.1111/j.1600-0897.1995.tb00947.x

M3 - Article

C2 - 8579761

AN - SCOPUS:0028789319

VL - 34

SP - 236

EP - 240

JO - American Journal of Reproductive Immunology

JF - American Journal of Reproductive Immunology

SN - 8755-8920

IS - 4

ER -